Consolidated Balance Sheets - USD ($)	Jan. 31, 2020	Jul. 31, 2019
Current assets:
Cash and cash equivalents	$ 1,856,505	$ 1,731,095
Accounts receivable, net	791,340	264,558
Accounts receivable - related parties	1,069,713	1,009,397
Total current assets	3,717,558	3,005,050
Total assets	3,717,558	3,005,050
Current liabilities:
Accounts payable and accrued liabilities	25,621	41,104
Accounts payable - related parties	660,682	526,541
Advances from shareholders	1,000	1,000
Accrued interest	41,964	24,510
Settlement payable - related party	290,000	145,000
Convertible notes payable, net of discounts	30,000	30,000
Convertible notes payable, net- in default	10,000	10,000
Promissory note - related party	174,254	1,033,567
Derivative liabilities - note conversion feature	15,000	15,000
Total current liabilities	1,248,521	1,826,722
Settlement payable - related party - long-term		145,000
Total non-current liabilities		145,000
Total liabilities	1,248,521	1,971,722
Shareholders' equity (deficit):
Common stock: $0.00001 par value, 6,000,000,000 shares authorized, 2,845,318,757 and 2,845,318,757 shares issued and outstanding, respectively	28,453	28,453
Additional paid-in capital	27,894,312	27,443,293
Accumulated other comprehensive loss	(683)	(683)
Accumulated deficit	(25,453,045)	(26,437,735)
Total shareholders' deficit	2,469,037	1,033,328
Total liabilities and shareholders' deficit	3,717,558	3,005,050
Series A Preferred Stock [Member]
Shareholders' equity (deficit):
Preferred stock, Series A: $0.00001 par value; 19,999,000 shares authorized, none outstanding
Series B Preferred Stock [Member]
Shareholders' equity (deficit):
Preferred stock, Series B: $0.00001 par value, 1,000 shares authorized,1,000 and 1,000 shares issued and outstanding, respectively